Y. Maruyama

Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

S. Takeda, N. Hashimoto, Y. Miyagoe-Suzuki, 2020, Communications Biology.

iNOS is not responsible for nitrosylation of RyR1 in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020 .

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020, BMC Musculoskeletal Disorders.

Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR)

S. Takeda, Y. Miyagoe-Suzuki, Fusako Sakai-Takemura, 2021, Stem Cell Research & Therapy.

iNOS is not responsible for RyR1 S-nitrosylation in mdx mice with truncated dystrophin

J. Kira, S. Takeda, J. Tanihata, 2020, BMC Musculoskeletal Disorders.

Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

S. Takeda, N. Hashimoto, Y. Miyagoe-Suzuki, 2020, Communications Biology.

Pharmacological activation of SERCA ameliorates dystrophic phenotypes in dystrophin-deficient mdx mice

J. Kira, S. Takeda, Y. Aoki, 2021, Human molecular genetics.

Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy

S. Takeda, Y. Miyagoe-Suzuki, Fusako Sakai-Takemura, 2020, Muscular Dystrophy - Research Updates and Therapeutic Strategies.

Antioxidants restore store‐operated Ca2+ entry in patient‐iPSC‐derived myotubes with tubular aggregate myopathy‐associated Ile484ArgfsX21 STIM1 mutation via upregulation of binding immunoglobulin protein

Y. Aoki, K. Nogami, A. Elhussieny, 2023, FASEB bioAdvances.